SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-14-000714
Filing Date
2014-02-13
Accepted
2014-02-13 12:34:24
Documents
1
Period of Report
2014-02-06

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3623
  Complete submission text file 0001171843-14-000714.txt   5113
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Issuer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1275 W. WASHINGTON TEMPE AZ 85281
Business Address
FELDMAN FREDRIC J (Reporting) CIK: 0001191704 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33560 | Film No.: 14604375